Call for Abstracts

Meeting Format of the 55th Annual Congress of the Japan Epilepsy Society(As of March 1, 2022)

The 55th Annual Congress of the Japan Epilepsy Society is currently scheduled to be held as a hybrid on-site/online meeting. The format will differ depending on the session. The meeting may be held entirely online should the situation related to COVID-19 change.

* The latest information will be posted on this website as it becomes available.

Submission of abstracts

• Abstracts must be submitted online via the UMIN system.
• If entered in Japanese, the name of the first author and abstract title must also be entered in English.
• The text of the abstract can be prepared in Japanese or English, even if the presentation is in Japanese.
• Speakers at sessions with other speakers from overseas are requested to submit their abstracts in English.
• The presenter is the first author of an oral presentation. Foreign national presenters (of oral presentations) who are currently studying in Japan are exempt from registration fees.

Abstract categories

Oral presentations	Designated presentations (other than above)
Open call	Nominated * Open only to nominated individuals. 　Abstracts submitted by individuals other than those nominated are ineligible for this category.

Abstract submission period

Oral presentations: March 28 (Mon.) to April 28 (Thu.), 2022May 9 (Mon.), 2022 12:00 p.m.
Designated presentations: Nominated speakers will be contacted individually.

Presentation style

Oral presentations

Only oral presentations will be livestreamed. If the situation with COVID-19 allows, oral presentations may be combined with a poster display at the venue on the day of the presentation. Following a peer review and rigorous screening of submitted abstracts by the program committee, you will be notified by email of the decision regarding acceptance, presentation format and abstract number (scheduled for early June 2022).

Designated presentations

Oral presentation

* If you require any special considerations on the day of the presentation, please provide details by checking the relevant box when submitting your abstract (i.e., use of a wheelchair, etc.)

Eligibility and conditions

Ethical considerations

Abstracts will be accepted for peer review following confirmation that there are no ethical issues related to the study. Presenters must adhere to the “Declaration of Helsinki” and must bear ethical responsibility for their presentations. Please answer the questions concerning ethical issues at the time of abstract submission. If there are no ethical issues with the contents of your presentation, you do not have to state that in the abstract. Please make certain that you do not disclose private information regarding patients involved in the study.

Abstract overlap

All abstracts must be original and previously unpublished. If your abstract for this congress overlaps with one for another presentation, please send a copy of that other abstract to the Secretariat of the 55th Annual Congress of the Japan Epilepsy Society.

JES membership status of first author

The first author must be a regular member or temporary member of the Japan Epilepsy Society. If you are not a member, please apply for membership at the time of abstract submission. More than one regular member must be included as a co-author when a presentation is given by a temporary member.

Points to note when submitting an abstract

1. Number of words

	Oral Presentation (Japanese, English)		Designated Presentation (other than oral presentation)
	[Japanese]	[English] including spaces	[Japanese]	[English] including spaces
Title	Less than 50 characters (full-width)	Less than 25 words (half-width)	Less than 50 characters (full-width)	Less than 25 words (half-width)
Text*	Less than 800 characters (full-width)	Less than 220 words (half-width)	Less than 1,200 characters (full-width)	Less than 350 words (half-width)
Total number of words/characters (author name(s), affiliation(s), abstract title and text)	Less than 1,100 characters (full-width)	Less than 300 words (half-width)	Less than 1,500 characters (full-width)	Less than 430 words (half-width)

* Please structure the abstract using the following headings: Objectives, Subjects and Methods, Results, Conclusion.

2. Presentation format or session title for designated presentation

* Please select one of the following.

Oral Presentation

1	Oral Presentation (Japanese, English)

Designated Presentation

2	Educational Lecture
3	Symposium or Workshop
4	Training Course for Medical Advisors
5	Other

Category

If you have selected Oral Presentation as your presentation format, please select your first and second choice categories from the list below.

01. Etiology/Epidemiology
02. Underlying condition/Disease
03. Classification/Syndrome
04. Genetics
05. Ictal semiology
06. EEG/MEG/Neurophysiology
07. Neuroimaging
08. Medication
09. Surgery
10. Other treatment
11. Clinical course/Prognosis
12. Social aspect/QOL
13. Comorbidity
14. Psychiatric symptom
15. Development/Neuropsychology
16. Comprehensive/Integrated care
17. Medical system
18. Medical staff session
19. Adverse effect
20. Pharmacology
21. Physiology
22. Pathology
23. Biochemistry
24. Neurotransmitter
25. Experimental epilepsy
26. Case report
27. Art, History

Awards

Excellent Presentation Award
Awards will be presented to the best abstract from the Oral Presentations.
Requirements: First author must be under 40 years of age (as of April 1, 2022). If you wish to apply for the Award, please indicate this at the time of your abstract submission.

Disclosure of Conflicts of Interest (COI)

1. The Japan Epilepsy Society requires all presenters to declare and disclose any Conflicts of Interest (COI) in order to promote the proper conduct of clinical research between industry and academia and to ensure neutrality and transparency in presenting the results of clinical research that has been carried out in a scientific and ethical manner. Please answer questions concerning COI at the time of your abstract submission.
2. If you check, “There are items that apply, so I will submit a declaration form”, please download and fill in “Form 1: Disclosure of Conflict of Interest (COI) by First Author” before sending it to the Secretariat by email (see below).
3. Please submit the COI Form 1 immediately after submitting your abstract.
   The deadline for submission: May 31 (Tue.), 2022.

* For more detailed information on the Policy on Conflicts of Interest (COI) in Clinical Research, click here.

Please contact the Secretariat of the Japan Epilepsy Society (see below) for any technical questions on COI.

COI Disclosure Form (Template) for Oral and Poster Presentations
Form 2: Disclosure of COI

Abstract submission